Finding solutions to ‘undruggable’ biotargets for cancer therapy

Finding solutions to ‘undruggable’ biotargets for cancer therapy

October 30, 2018
Texas A&M researchers utilized CRISPR-Cas gene editing technology to define a biochemical pathway for cancer treatment